Showing 7,355 news articles about Health services & systems

Filters Content type: Editors' picks Topic: Health services & systems

Getting the most from doctors, nurses, pharmacists and other healthcare providers.

New & experimental hepatitis C treatment

Pharmasset rises on new hepatitis C drug studies

Editor's pick
Bloomberg BusinessWeek
2 November 2011
New & experimental hepatitis C treatment

TMC435-Based Therapy Significantly Improved Viral Cure Rates in Patients Who Failed Prior Treatment for Hepatitis C

Editor's pick
Business Wire
2 November 2011
Global health initiatives

Global health fund uncovers $20 million more in losses through corruption in new probes

Editor's pick
Washington Post
2 November 2011
Pharmaceutical industry

DFH Pharma Obtains Exclusive Rights to Second-Generation HIV Maturation Inhibitor Program

Editor's pick
DFH press release
1 November 2011
New & experimental hepatitis C treatment

Pharmasset Takes Lead in Race to Develop Hep C Therapy By Pill

Editor's pick
The Street
1 November 2011
Health services & systems

Treatment Costs Higher When HIV Diagnosis Is Delayed

Editor's pick
Medscape (free registration required)
1 November 2011
Finance & funding

Doctors criticise London HIV drugs cost-cutting deal

Editor's pick
BBC
1 November 2011
Epidemiology

China reports 60,000 new HIV/AIDS cases

Editor's pick
China Daily
31 October 2011
Global health initiatives

Fate of Bush-era program a matter of life or death

Editor's pick
CNN
31 October 2011
Improving HIV care

Abolishing user fees - does the reality match up to the dream?

Editor's pick
The Guardian
31 October 2011
Tuberculosis & HIV

Straight talk with Stop TB Director Mario Raviglione

Editor's pick
IRIN Plus News
31 October 2011
Young people

Can crowd sourcing solve the challenges posed by the HIV epidemic?

Editor's pick
Incidence 0
29 October 2011
Tuberculosis & HIV

Gates Foundation lays out revamped TB strategy

Editor's pick
Science Speaks
28 October 2011
Pharmaceutical industry

Over the Next Decade, the Dominance of Bristol-Myers Squibb Company 's Atripla in the HIV Drug Market Will Be Challenged by Gilead's Quad and Janssen's Complera

Editor's pick
Business Wire
28 October 2011
Pharmaceutical industry

Gilead posts higher profit, seeks Quad approval

Editor's pick
Reuters
27 October 2011
UK health services

UK Government Response to Lords Committee on HIV and AIDS

Editor's pick
Department of Health
27 October 2011
Types of HIV tests

HIV test kit company halts production following FDA inspections

Editor's pick
MedCity News
26 October 2011
New & experimental HIV treatments

BMS to develop Reyataz fixed-dose pill with Gilead booster drug

Editor's pick
MarketWatch
26 October 2011
Finance & funding

Treatment Action Global TB R&D Investment Trends 2010 Funding Flat at $617 million, Less Than One-Third of the Global Need

Editor's pick
Treatment Action Group
26 October 2011
Finance & funding

Zimbabwe: Funding Threatens HIV/TB Fight

Editor's pick
AllAfrica
26 October 2011
Improving HIV care

Standard definition of loss-to-follow-up for ART patients

Editor's pick
Eurekalert Inf Dis
25 October 2011
Pharmaceutical industry

Innovative transdermal patch for delivery of HIV medicine

Editor's pick
Science Daily
25 October 2011
Global health initiatives

Focus on HIV-Aids cost family planning a decade, says UN population chief

Editor's pick
The Guardian
24 October 2011
New & experimental hepatitis C treatment

Vertex study will evaluate 12-week treatment period for some hepatitis C patients

Editor's pick
Boston.com
24 October 2011